Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene Cream, 0.005%

capital market | Mumbai | June 11, 2015 00:00 IST

Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene Cream, 0.005%

Glenmark Pharmaceuticals has been granted final approval by the United State Food & Drug Adminstration for Calcipotriene Cream, 0.005%, the therapeutic equivalent of Dovonex Cream, 0.005% of Leo Pharma A/S. Glenmark plans to commence shipping of Calcipotriene Cream, 0.005% immediately.